The global inhaled nitric oxide market is experiencing strong growth momentum, supported by increasing clinical adoption in neonatal intensive care and rising prevalence of respiratory and cardiopulmonary disorders worldwide. The market was valued at USD 1034.21 million in 2025 and is projected to grow from USD 1121.09 million in 2026 to USD 2137.34 million by 2034, registering a CAGR of 8.4% during 2026–2034.
Inhaled nitric oxide is a selective pulmonary vasodilator widely used in critical care settings, particularly for treating hypoxemic respiratory failure in newborns. Its ability to improve oxygenation and reduce pulmonary vascular resistance has made it a key therapeutic tool in neonatal intensive care units (NICUs) globally.
Market Dynamics & Core Insights
A major driver of market growth is the rising incidence of neonatal respiratory disorders, including persistent pulmonary hypertension of the newborn (PPHN), meconium aspiration syndrome, and respiratory distress syndrome. These conditions significantly contribute to neonatal mortality, with hypoxic respiratory failure affecting a substantial proportion of live births globally.
Increasing prevalence of chronic diseases such as COPD and pulmonary hypertension is also expanding the clinical use of inhaled nitric oxide beyond neonatal care. COPD alone affects tens of millions of patients globally and is frequently associated with secondary pulmonary hypertension, increasing demand for advanced pulmonary therapies.
Technological advancements in nitric oxide delivery systems, including improved dosing precision and portable administration devices, are further enhancing adoption across healthcare facilities. However, high treatment costs and limited reimbursement frameworks continue to restrict broader accessibility, particularly in developing regions.
North America remains the dominant regional market due to advanced healthcare infrastructure, high R&D investment, and strong neonatal care adoption. Asia Pacific is emerging as the fastest-growing region, driven by high birth rates, increasing neonatal care awareness, and expanding healthcare infrastructure.
Key Market Players Section
- Air Liquide S.A. – A global leader in medical gases, focusing on advanced nitric oxide delivery systems and expanding its presence in respiratory care solutions.
- Bellerophon Therapeutics Inc. – Specializes in innovative inhaled nitric oxide therapies targeting pulmonary hypertension and fibrotic lung diseases.
- BOC Healthcare – Provides respiratory gas technologies and supports hospital-grade nitric oxide delivery systems across critical care settings.
- Beyond Air Inc. – Focuses on ultra-high concentration nitric oxide therapies and expanding clinical applications beyond traditional neonatal use.
- Halma Plc – Develops medical and safety technologies, including gas delivery and monitoring systems used in healthcare and industrial applications.
Industry Impact / Future Outlook
Over the next decade, the inhaled nitric oxide market is expected to evolve beyond its traditional neonatal applications into broader therapeutic areas, including COPD, ARDS, and emerging pulmonary conditions. Ongoing clinical trials exploring expanded indications may significantly widen its clinical utility.
Advancements in portable and cost-efficient delivery systems are expected to improve accessibility and reduce treatment burden in hospitals. Additionally, increasing global focus on neonatal health outcomes and respiratory disease management will continue to drive demand.
While cost remains a key barrier, innovation in delivery technologies and potential expansion of insurance coverage are likely to improve adoption rates. Overall, the market is positioned for sustained long-term growth driven by both clinical necessity and technological progress.
Click to Download and Read the Full Report: https://straitsresearch.com/report/inhaled-nitric-oxide-market
About Straits Research
Straits Research is a leading global market intelligence and consulting firm delivering in-depth research reports, strategic insights, and data-driven analysis across multiple industries. With a strong global presence, Straits Research supports businesses, investors, and decision-makers with actionable intelligence to navigate evolving market landscapes and identify high-growth opportunities.
